Primary Peritoneal Carcinoma [clinicaltrials_resource:aee27413c1d2847aa4c1401956a94140]
CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00045682]Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00054119]Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00060359]clinicaltrials:NCT00072566Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels [clinicaltrials:NCT00083928]Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer [clinicaltrials:NCT00093626]Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer [clinicaltrials:NCT00214058]clinicaltrials:NCT00322881Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer [clinicaltrials:NCT00352300]clinicaltrials:NCT00407563clinicaltrials:NCT00499252clinicaltrials:NCT00511992Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy [clinicaltrials:NCT00551265]clinicaltrials:NCT00561795clinicaltrials:NCT00582205Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer [clinicaltrials:NCT00659178]clinicaltrials:NCT00721162Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [clinicaltrials:NCT00814086]OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission [clinicaltrials:NCT00857545]clinicaltrials:NCT00868192Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy [clinicaltrials:NCT00899093]clinicaltrials:NCT00939809clinicaltrials:NCT01031381clinicaltrials:NCT01091259clinicaltrials:NCT01097746EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [clinicaltrials:NCT01118052]clinicaltrials:NCT01138137Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer [clinicaltrials:NCT01139957]Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer [clinicaltrials:NCT01180504]clinicaltrials:NCT01202890Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients [clinicaltrials:NCT01308944]Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma [clinicaltrials:NCT01381861]Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer [clinicaltrials:NCT01442051]Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 [clinicaltrials:NCT01445275]clinicaltrials:NCT01504126clinicaltrials:NCT01506856Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma [clinicaltrials:NCT01519869]clinicaltrials:NCT01535157clinicaltrials:NCT01588522clinicaltrials:NCT01611766
condition [clinicaltrials_vocabulary:condition]
Primary Peritoneal Carcinoma [clinicaltrials_resource:aee27413c1d2847aa4c1401956a94140]
Bio2RDF identifier
aee27413c1d2847aa4c1401956a94140
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:aee27413c1d2847aa4c1401956a94140
identifier
clinicaltrials_resource:aee27413c1d2847aa4c1401956a94140
title
Primary Peritoneal Carcinoma
@en
label
Primary Peritoneal Carcinoma [clinicaltrials_resource:aee27413c1d2847aa4c1401956a94140]
@en